204 related articles for article (PubMed ID: 33104975)
1. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
2. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.
Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052
[TBL] [Abstract][Full Text] [Related]
3. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
4. The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study.
de Haan-Du J; Landman GWD; Groenier KH; Vissers PAJ; Louwman MWJ; Kleefstra N; de Bock GH
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2114-2121. PubMed ID: 34493493
[TBL] [Abstract][Full Text] [Related]
5. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
6. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW;
J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517
[TBL] [Abstract][Full Text] [Related]
7. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
Park E; Lee Y; Jue MS
Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
[TBL] [Abstract][Full Text] [Related]
8. Skin Cancer and Hydrochlorothiazide: Novel Population-Based Analyses Considering Personal Risk Factors Including Race/Ethnicity.
Birck MG; Moura CS; Machado MAA; Liu JL; Abrahamowicz M; Pilote L; Bernatsky S
Hypertension; 2023 Oct; 80(10):2218-2225. PubMed ID: 37489540
[TBL] [Abstract][Full Text] [Related]
9. Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population?
Carney K; Cousins M
Evid Based Dent; 2022 Mar; 23(1):38-39. PubMed ID: 35338330
[TBL] [Abstract][Full Text] [Related]
10. COX-2 inhibitors show no preventive effect in the development of skin cancer.
Yen H; Yen H; Drucker AM; Han J; Li WQ; Li T; Qureshi A; Cho E
J Dtsch Dermatol Ges; 2022 Feb; 20(2):157-166. PubMed ID: 35088518
[TBL] [Abstract][Full Text] [Related]
11. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
12. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.
Morales DR; Pacurariu A; Slattery J; Kurz X
Br J Clin Pharmacol; 2020 Jul; 86(7):1336-1345. PubMed ID: 32068906
[TBL] [Abstract][Full Text] [Related]
13. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study.
Lecaros-Astorga DA; Molina-Guarneros JA; Rodríguez-Jiménez P; Martin-Arias LH; Sainz-Gil M
Int J Clin Pharmacol Ther; 2021 Apr; 59(4):280-288. PubMed ID: 33355085
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML
J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677
[TBL] [Abstract][Full Text] [Related]
15. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
16. RF - Thiazide Diuretics and Nonmelanoma Skin Cancer.
Rodríguez-Jiménez P; Lecaros-Astorga D; Martin-Arias LH
Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):176-177. PubMed ID: 33022224
[No Abstract] [Full Text] [Related]
17. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.
Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW
CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer.
Lian Y; Yin H; Pollak MN; Carrier S; Platt RW; Suissa S; Azoulay L
Eur Urol; 2016 Nov; 70(5):808-815. PubMed ID: 27178449
[TBL] [Abstract][Full Text] [Related]
19. Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma.
Pottegård A; Pedersen SA; Schmidt SAJ; Hölmich LR; Friis S; Gaist D
JAMA Intern Med; 2018 Aug; 178(8):1120-1122. PubMed ID: 29813157
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
J Am Heart Assoc; 2022 Dec; 11(24):e026789. PubMed ID: 36515246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
